Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Non Operating Income (2021 - 2025)

Lucid Diagnostics' Non Operating Income history spans 5 years, with the latest figure at $6.1 million for Q4 2025.

  • For Q4 2025, Non Operating Income rose 633.21% year-over-year to $6.1 million; the TTM value through Dec 2025 reached $1000.0, down 99.81%, while the annual FY2024 figure was $523000.0, 112.5% up from the prior year.
  • Non Operating Income reached $6.1 million in Q4 2025 per LUCD's latest filing, up from $1.4 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $6.9 million in Q2 2025 to a low of -$14.4 million in Q1 2025.
  • Average Non Operating Income over 5 years is -$223052.6, with a median of $28000.0 recorded in 2022.
  • The largest YoY upside for Non Operating Income was 4975.0% in 2023 against a maximum downside of 193100.0% in 2023.
  • A 5-year view of Non Operating Income shows it stood at -$65000.0 in 2021, then surged by 172.31% to $47000.0 in 2022, then surged by 1225.53% to $623000.0 in 2023, then surged by 33.87% to $834000.0 in 2024, then soared by 633.21% to $6.1 million in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Non Operating Income are $6.1 million (Q4 2025), $1.4 million (Q3 2025), and $6.9 million (Q2 2025).